NCT05890235View on ClinicalTrials.gov

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

323

Participants

Timeline

Start Date

November 16, 2018

Primary Completion Date

July 10, 2022

Study Completion Date

July 10, 2022

Conditions

Chronic Prostatitis

Interventions

DRUG

Ningmitai Capsule

Ningmitai Capsule (Ningmitai®) is Traditional Chinese Medicine which has already used in treatment of urinary system disease (eg. CPPS, BPH) in China for more than twenty years. The instruction of Ningmitai Capsule is 0.38g/capsule, 4 capsule/time, tid.

DRUG

Tamsulosin Hydrochloride

Tamsulosin is α1A-adrenergic receptor which has used in treatment of BPH for few years. The instruction of Tamsulosin Capsule is 1 tablet at a time, 1 time a day.

Trial Locations (1)

Unknown

The first affiliated hospital of Anhui medical university, Hefei

All Listed Sponsors

lead

Xintian Pharmaceutical

INDUSTRY

NCT05890235 - Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome | Biotech Hunter | Biotech Hunter